Ciena reported strong Q2 results, delivering earnings per share of $1.64, surpassing the expected $1.46, and achieving 40% year-over-year revenue growth to $1.57 billion. The company raised its full-year 2026 revenue guidance to $6.3 billion and operating margin to 19%, supported by a $7.7 billion backlog and new contracts with hyperscalers. Ciena's financial health is solid, with a 13.9% free cash flow margin, improved cash conversion cycle, and a nearly net-cash balance sheet. The positive outlook and robust business fundamentals suggest long-term growth potential despite a premium valuation.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
